No definition available.
Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
C3_THYROID_MEDULLARY_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
73 |
4. Check minimum number of eventsNone |
73 |
5. Include endpointsNone |
73 |
6. Filter based on genotype QC (FinnGen only) |
73 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 73 | 53 | 20 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 47.61 | 45.64 | 52.83 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
60
0
+∞
77.45
9.8
0.0
pmol/l
711.8
—
—
42
0
(4035726)
28
16
27.77
36.09
1.5
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
37
9
80.75
34.17
2.9
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
36
8
86.16
33.63
2.6
1.3
nmol/l
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
27
5
83.87
25.15
5.0
1.2
u/ml
16.8
—
—
7
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
6
51.33
18.91
1.8
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
63
245
12.47
17.52
11.3
4.3
mmol/l
1.2
1.2
1.29
63
222
(3018418) pH of Serum or Plasma
48
159
6.90
15.08
9.9
2.6
ph
7.4
7.4
—
9
25
(3044640) Blood type and Crossmatch panel - Blood
35
153
3.47
6.35
3.1
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
47
251
3.45
6.09
4.6
3.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
40
195
3.33
6.00
2.6
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
21
69
3.87
5.78
5.4
1.8
mmol/l
0.8
0.8
0.15
21
62
(3002256) Pathology report gross observation
16
45
4.27
5.40
1.4
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
26
122
2.76
3.86
2.8
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
44
286
2.36
3.12
10.6
3.4
umol/l
10.2
10.8
0.38
44
266
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
17
5.14
3.01
1.9
1.8
ug/l
166.9
2.9
—
8
17
(3032080) INR in Blood by Coagulation assay
35
210
2.28
2.95
14.8
6.8
inr
1.4
1.2
—
8
60
(3013650) Neutrophils [#/volume] in Blood by Automated count
48
338
2.23
2.64
8.4
5.5
e9/l
3.5
4.2
1.86
43
294
(3019060) Gas panel - Arterial blood
9
26
3.80
2.58
6.0
3.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
24
129
2.28
2.57
5.8
5.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
58
2.75
2.55
2.8
4.2
mmol/l
1.1
1.0
0.17
14
52
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
23
3.77
2.35
3.0
7.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
11
43
2.83
2.21
4.9
6.1
g/l
125.4
127.7
0.14
11
43
(3036481) Cortisol [Moles/volume] in Serum or Plasma
13
56
2.61
2.20
1.9
1.6
nmol/l
521.1
410.4
0.25
13
51
(3003694) ABO and Rh group [Type] in Blood
25
145
2.10
2.18
1.5
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
5
10
5.27
2.10
3.8
3.6
mmol/l
9.0
9.9
—
5
10
(3018572) Chloride [Moles/volume] in Blood
5
10
5.27
2.10
3.8
3.6
mmol/l
108.4
106.0
—
5
10
(3052851) Hemolysis interference index of Serum or Plasma
6
16
3.99
1.98
1.7
2.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
24
3.11
1.77
1.9
5.8
mmol/l
26.8
25.0
—
7
24
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
67
589
2.67
1.77
18.4
9.5
ml/min/173m2
87.9
81.4
1.62
60
462
(3044889) 12 lead EKG panel
51
405
1.86
1.60
4.9
3.4
—
—
—
0
0
(3019225) pH of Specimen
12
59
2.24
1.54
16.2
4.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
22
2.88
1.46
1.3
1.7
%
0.9
0.6
—
6
22
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
23
2.75
1.40
1.3
1.7
%
0.9
0.8
—
6
23
(3022313) Gas panel - Capillary blood
5
17
3.08
1.38
8.8
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
34
2.52
1.34
1.8
7.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
34
432
0.60
1.30
3.7
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
38
2.24
1.23
4.8
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
26
184
1.64
1.13
4.3
5.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
34
2.17
1.06
2.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
54
1.99
1.02
2.1
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
29
0.00
1.00
0.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
30
0.00
1.00
0.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
55
1.95
0.97
2.1
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
9
52
1.83
0.96
1.7
1.9
u/l
28.7
30.0
—
9
40
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
27
2.33
0.96
6.0
7.9
%
0.5
0.7
—
6
27
(3002032) Base excess in Venous blood by calculation
8
44
1.92
0.89
1.4
2.6
mmol/l
3.1
1.8
—
8
33
(3012544) pH of Venous blood
8
46
1.83
0.86
1.4
2.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
13
192
0.61
0.83
3.7
3.9
mg/mmol
1.6
7.0
—
8
115
(3023368) Bacteria identified in Blood by Culture
17
117
1.59
0.81
4.4
3.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
75
1.72
0.81
2.2
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
24
0.00
0.81
0.0
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
57
507
1.57
0.79
21.7
12.8
%
13.5
13.5
0.21
57
500
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
7
41
1.78
0.72
2.7
2.1
g/l
0.2
0.2
—
7
36
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
27
1.91
0.70
6.8
8.1
%
1.3
1.6
—
5
27
(3041096) Erythrocytes [Presence] in Urine by Automated
12
173
0.63
0.68
2.9
3.4
—
—
—
0
0
(3015736) pH of Urine
19
246
0.69
0.64
2.8
3.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
235
0.69
0.63
2.8
3.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
11
73
1.60
0.60
3.5
2.1
umol/l
5.3
5.0
0.11
11
61
(3042936) Bacteria identified in Isolate by Culture
11
74
1.57
0.57
1.5
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
10
143
0.65
0.54
2.9
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
18
138
1.40
0.52
1.9
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
71
1.47
0.42
1.7
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
16
0.00
0.41
0.0
1.5
—
128.1
—
0
8
(3050129) First trimester maternal screen panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
17
0.00
0.41
0.0
4.8
—
19.9
—
0
11
(3004616) Nuclear Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
0.2
—
0
19
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
1.2
—
0
19
(40761535) Cells panel - Urine sediment
6
42
1.47
0.36
3.3
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
92
1.36
0.34
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
46
1.33
0.34
2.2
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
173
0.76
0.33
2.3
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
65
1.26
0.28
1.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
37
1.38
0.24
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
39
1.30
0.23
2.4
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
65
626
1.35
0.23
17.5
10.7
mg/l
28.6
20.6
1.01
52
464
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
113
0.77
0.22
1.3
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
8.6
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
3.0
—
14.0
—
0
11
(4306422)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.2
—
4960.8
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
94.4
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
119
1.22
0.19
1.1
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
17
193
0.84
0.18
2.3
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
22
244
0.86
0.18
2.7
3.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
71
1.14
0.17
1.8
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
55
568
0.87
0.13
20.5
11.4
%
41.4
40.3
0.51
47
418
(3007164) IgA [Mass/volume] in Serum or Plasma
14
124
1.16
0.12
1.6
1.3
g/l
1.7
2.5
—
6
67
(3027945) Reticulocytes/100 erythrocytes in Blood
6
53
1.14
0.09
3.7
2.8
%
1.7
1.4
—
6
47
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
54
1.12
0.09
1.5
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
22
235
0.91
0.09
1.8
1.8
pmol/l
83.0
104.9
1.26
11
110
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
61
0.81
0.08
1.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
60
0.82
0.08
2.2
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
63
1.12
0.08
1.1
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
72
0.82
0.08
11.5
5.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
89
1.14
0.07
1.5
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
14
152
0.90
0.07
2.5
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
103
0.86
0.07
1.9
2.0
—
—
—
0
0
(3013512) EKG study
19
179
1.08
0.05
5.1
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
40
389
1.06
0.04
2.5
3.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
24
230
1.06
0.04
3.8
3.1
ng/l
19.5
51.3
1.12
19
154
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
10
93
1.09
0.02
4.3
3.2
%
27.3
24.3
—
5
40
(3018095) Leukocytes [#/volume] in Urine
20
206
0.96
0.00
2.8
3.8
e6/l
102.9
70.3
0.13
14
139
(3021589) Normoblasts [#/volume] in Blood
25
247
1.02
0.00
9.4
7.6
e9/l
0.0
0.0
0.00
18
198
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4024509)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
54
0.92
0.00
1.4
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
7.6
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.5
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
62.0
—
0
6
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
5.8
—
0
6
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
1.7
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
405.6
—
0
5
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(4268621)
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
6
68
0.87
0.00
2.2
1.5
%
1.3
1.3
—
6
61
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
66
0.90
0.00
2.0
2.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
61.7
—
0
6
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
3.8
—
20.6
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
12.6
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYROID_MEDULLARY_EXALLC – Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).